# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-18T00:03:33.980610
**Route:** OpenRouter + LaTeX
**Tokens:** 19481 in / 1155 out
**Response SHA256:** c92f11db21851cbe

---

No fatal errors detected in the supplied LaTeX source under the four categories you specified.

### 1) DATA–DESIGN ALIGNMENT (CRITICAL)
- **Treatment timing vs. data coverage:** Treatment cohorts run from **2018 Q2 through 2024 Q1** (Table `\ref{tab:treatment}`), while the analysis data cover **Jan 2018–Dec 2024** (84 months). This is internally feasible: the latest-treated cohort (OR, 2024 Q1) still has post-treatment months available in 2024.
- **Post-treatment observations:** The paper explicitly notes that late-treated cohorts have limited post periods but still nonzero post-treatment support within the sample window; nothing implies a cohort is treated after the panel ends.
- **Treatment definition consistency:** The treatment is consistently described as “first month/quarter of sustained ≥15% increase,” and the regression treatment variable is consistently “Post Rate Increase / PostTreat.” Table `\ref{tab:treatment}` aligns with this.

### 2) REGRESSION SANITY (CRITICAL)
Checked all reported regression outputs in:
- Table `\ref{tab:main}`
- Table `\ref{tab:cs_did}`
- Table `\ref{tab:robustness}`
- Table `\ref{tab:sa}`
- Appendix validation/treatment tables

Findings:
- No impossible statistics (no negative SEs; no R² outside [0,1] reported; no NaN/Inf/NA).
- Standard errors are not explosively large relative to coefficients (no obvious collinearity artifacts in the presented results).
- Coefficient magnitudes are plausible for log outcomes (all far below |10|).

### 3) COMPLETENESS (CRITICAL)
- All main regression tables report **standard errors** and **sample size/observations** (Table `\ref{tab:main}` and `\ref{tab:cs_did}` clearly do; Table `\ref{tab:robustness}` provides N details in notes).
- No obvious placeholders like TBD/TODO/XXX/NA in tables.
- Referenced tables/appendix sections included in the provided source appear to exist (e.g., `\ref{tab:validation}`, `\ref{tab:treatment}`, `\ref{tab:sa}`, `\ref{sec:appendix_sensitivity}`).

### 4) INTERNAL CONSISTENCY (CRITICAL)
- Sample window is consistently stated as 2018–2024 / 84 months.
- Jurisdiction counts are consistent: 52 jurisdictions in analysis; treatment/control split 20 treated + 32 never-treated is coherent.
- The CI cited in the introduction for the TWFE provider effect matches Table `\ref{tab:main}` Column (1) (CI `[-0.504, 0.373]`).

ADVISOR VERDICT: PASS